Reduced levels of TNFα have been linked to an amelioration of NAFLD, since anti-TNFα antibodies were reported to improve liver histology, to reduce circulating levels of AST and ALT, and to diminish hepatic fat content [34]. This evidence concerns the gene TNF and metabolic dysfunction-associated steatotic liver disease.